Table 1.

Characteristics of 9 patients who underwent renal artery embolization after hemorrhage.

Patient number	Sex	Age (years)	Tumor		Pathology	Surgery for renal tumor	TOE (days)	Interventional therapy		Clinical Success	Follow-up (months)
			Size (mm)	Location				Angiography	Embolization
1	Female	42	28	Mesorenal	RCCC	OPN	6	RAP	Coil, Lipiodol, PVA	Yes	96
2	Male	40	50	Lower pole	Renal hamartoma	OPN	1	Hemorrhage	Gelfoam	Yes	85
3	Female	42	30	Mesorenal	CRCC	OPN	5	Hemorrhage (suspicious)	Microcoil	Yes	84
4	Male	71	30	Lower pole	RCCC	OPN	15	RAP	Microcoil, coil	Yes	82
5	Male	26	83	Mesorenal	Renal hamartoma	OPN	30	Hemorrhage, RAVF	Microcoil, Gelfoam	No	68
6	Male	43	42	Lower pole	RCCC	LPN	8	Hemorrhage	Microcoil	Yes	37
7	Female	34	39	Lower pole	RCCC	LPN	1	Hemorrhage, RAP	Microcoil, coil, Gelfoam	No	35
8	Female	44	30	Mesorenal	RCCC	LPN	11	RAP, RAVF	Microcoil, Coil, Gelfoam	Yes	8
9	Male	76	40	Mesorenal and lower pole	RCCC	RLPN	1	RAP	Microcoil, Gelfoam	No	6

RCCC = renal clear cell carcinoma, LPN = laparoscopic partial nephrectomy, OPN = open partial nephrectomy, RLPN = robot-assisted laparoscopic partial nephrectomy, RAP = renal arterial pseudoaneurysm, RAVF = renal arteriovenous fistula, TOE = time to embolization (days), PVA = polyvinyl alcohol.